Highlights of ASH in Asia

Last Modified: January 17, 2013

Dates: March 23-24, 2013
Location: Shanghai, China

Sponsoring Group: The American Society of Hematology

Web Page URL: www.hematology.org/calendar_HOAAsia

Topics Covered: Acute Myeloid Leukemia Bone Marrow Failure Chronic Lymphocytic Leukemia Disorders of Hemostasis Hematopoietic Stem Cell Transplantation Hodgkin and Non-Hodgkin Lymphoma Myelodysplastic Syndromes Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia Novel Treatments for Relapsed/Refractory Chronic Immune Thrombocytopenia Plasma Cell Disorders (Myeloma) Thrombosis and Anticoagulation Thrombotic Thrombocytopenic Purpura (TTP)/Hemolytic Uremic Syndrome (HUS) and Atypical HUS

Objectives: At Highlights of ASH you will:

  • Examine advances in clinical and translational hematologic research
  • Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of people with blood diseases
  • Discuss new patient management and care strategies with leading faculty in the field

Fees: $125-275

Continuing Education: No

Blogs

Hand Washing Saves Patients' Lives
by Rodney Warner, JD
January 20, 2015

Is Ayurveda the Answer to Women’s Health Issues?
by The 4Wholeness Team
September 01, 2015

Related News

ASH: Hodgkin's Lymphoma Tx Shows Promise in Small Trial

Dec 9, 2014

Nivolumab harnesses power of immune system in patients who've failed other therapy


ASH: Carfilzomib Ups Survival in Relapsed Multiple Myeloma

Dec 9, 2014

Improved progression-free survival with addition of carfilzomib to lenalidomide and dexamethasone


ASH: CALR Mutations ID'd in Myeloproliferative Neoplasms

Dec 11, 2013

Two studies show somatic mutations in CALR for most patients with nonmutated JAK2